Introduction {#sec1-1}
============

Ischemic heart disease constitutes a wide spectrum of syndromes caused by myocardial supply and demand imbalance. Coronary revascularization procedures focus only on central aspect of this critical equilibrium, but it is increasingly being re- cognized that peripheral factors are also crucially important for an optimal cardiovascular performance ([@ref1], [@ref2]). Exercise-based cardiac rehabilitation (CR) is a multifaceted intervention with favorable effects that extend beyond coronary vasculature ([@ref3], [@ref4]). It may have a comparable efficacy to coronary revascularization in improving symptom-free exercise tolerance, maximum exercise capacity, and survival, even in patients with angiographically documented stenosis amenable for intervention ([@ref4], [@ref5]). CR may show these beneficial effects not only by increasing supply via a healthier coronary endothelial function ([@ref6]), but also by lowering demand via an improved mechanical efficiency ([@ref7], [@ref8]) and vascular load ([@ref9]--[@ref11]). On the other hand, baseline supply--demand imbalance may have a negative effect on CR success and may be frustrating by causing time and resource consumption.

Although it may be difficult to estimate myocardial supply--demand ratio precisely, many clinical methods were proposed for its evaluation. A practical reflection of this information resides in the aortic pressure curve. While the systolic part of the aortic pressure curve reflects afterload and the area under it represents a measure of myocardial oxygen consumption ([@ref12], [@ref13]), the diastolic difference between aortic and ventricular pressure curves is a surrogate for diastolic coronary blood supply ([@ref14], [@ref15]). Thus, subendocardial viability ratio (SEVR), which consists of a diastolic to systolic pressure-time integral ratio, is an index of myocardial oxygen supply and demand ([Fig. 1](#F1){ref-type="fig"}) ([@ref16], [@ref17]). Aortic pressure curve also contains arterial stiffness and ventriculo-vascular interrogation data by means of wave reflections ([@ref18]). Given that both systolic and diastolic part of aortic pressure wave can be affected by reflected waves; myocardial supply--demand ratio may critically be influenced by peripheral vascular system. Until recently, invasive measurements were needed to elucidate this important interaction, but it has now become possible to construct aortic pressure curve noninvasively with the help of applanation tonometry.

We hypothesized that a suboptimal supply--demand balance, which may be caused by negative macrovascular characteristics, may limit favorable cardiac response to CR. To explore this hypothesis, we designed a study to analyze the association bet- ween SEVR and response to CR in patients with coronary artery disease (CAD).

![The key parameters for the calculation of subendocardial viability ratio (SEVR). SEVR is defined as diastolic pressure-time index (DPTI) divided by systolic pressure time index (SPTI). Diastolic pressure-time index is the area between aortic and left ventricular end-diastolic pressure (LVEDP) curves during diastolic time (DT), whereas systolic pressure-time index is the area under aortic pressure curve during systolic ejection period (SEP)](AJC-17-37-g001){#F1}

Methods {#sec1-2}
=======

Patients {#sec2-1}
--------

Study was executed at Hôpital Lariboisière, a tertiary center for CR. Consecutive outpatient CR referral requests were screened between November 2013 and May 2014. Patients with a history of recent (\<2 months) hospital admission for an acute coronary syndrome and/or revascularization procedure were included. Patients with non-sinus rhythms, severe valvular di- sease, left main CAD, uninterpretable electrocardiograms with respect to ischemic changes were excluded. Also it was planned that the patients with an ischemic response in first cardiopulmonary exercise test to be excluded. Patients were under optimized, stable treatment, and medications were not withdrawn or changed for the study. All patients gave their informed consent. The study was approved by the Local Ethical Committee.

Study protocol {#sec2-2}
--------------

Blood chemistry analysis, transthoracic echocardiography, arterial tonometry were performed before exercise training program. Echocardiographic examination was performed immediately following arterial tonometry and both examinations were done at the same day within two hours before the first cardiopulmonary exercise test.

Arterial tonometry {#sec2-3}
------------------

A high-fidelity tonometer (SphygmoCor Px PWA System, AtCor Medical, West Ryde, Australia) was used to obtain pressure waveforms by applying sufficient pressure over the left radial artery. The device was repositioned until the strongest pulse signal is identified. After the calibration with manually measured brachial blood pressure, sequential pressure waveforms were acquired to obtain an averaged peripheral waveform. A corresponding central waveform was derived using dedicated software utilizing wave transfer function. Only measures with a quality index above 80%, which represents reproducibility of the waveform, were included in this study. Systolic and diastolic time integrals were defined as the area under the systolic and diastolic parts of aortic pressure curve, respectively ([@ref19], [@ref20]). Diastolic time integral was corrected for left ventricular (LV) diastolic pressure, which was estimated echocardiographically, as detailed elsewhere ([@ref21]). SEVR was calculated as diastolic time integral divided by systolic time integral. Augmentation pressure (AP), was estimated by subtracting the pressure at the first peak shoulder of the aortic pulse wave from aortic systolic blood pressure. Augmentation index (AIx) was defined as AP divided by pulse pressure. AIx was corrected for an HR of 75 beats per minute (AIx\@75) as defined previously ([@ref22]).

Echocardiography {#sec2-4}
----------------

Two-dimensional images, flow and tissue Doppler recordings were obtained for all patients with use of a Doppler transthoracic echocardiograph with a 3.5-MHz transducer (GE Vivid I or 7, Horten, Norway). LV volumes were calculated by modified Simpson's biplane method from apical four chamber and two chamber views. Doppler recordings were obtained in the apical 4-chamber view by positioning sample volume at the tips of the mitral leaflets. The sample volume was positioned at the medial mitral annulus on apical 4-chamber view to measure early dias- tolic tissue Doppler velocity (E'). LV diastolic pressure was estimated as mitral inflow E wave divided by mitral septal annular E' wave ([@ref23]). All echocardiographic and tonometric examinations were performed by the same investigator (E.A.).

Exercise test {#sec2-5}
-------------

A standard advice including abstaining from smoking, coffee, heavy meals have been given to patients before the procedure. Exercise test was performed on a bicycle ergometer while patients were wearing a mask covering their mouth and nose for the measurements of breathing gases. Ventilation (V~E~), oxygen consumption (VO~2~), and carbon dioxide production (VCO~2~) were measured continuously on a breath-by-breath basis with a dedicated spirometer (Oxycon Pro Jaeger (San Diego, CA, USA). ECG was monitored continuously along with periodic manual blood pressure measurements. The workload was controlled by an electronically braked bicycle ergometer system.

Cycling rate was kept approximately at a rate of 60 cycling per minute with the help of a digital cyclometer. All patients were encouraged to exercise up to exhaustion (peak respiratory exchange ratio \>1.1) ([@ref24]). The peak oxygen pulse (πO~2~) was defined as peak VO~2~ divided by instantaneous heart rate. The percent predicted peak VO~2~ was calculated as peak VO~2~ divided by maximal predicted peak VO~2~ according to the values reported by Wasserman et al. ([@ref25]). Ventilatory threshold was measured by classical methods ([@ref26]). The peak circulatory power was defined as peak VO~2~ x peak systolic blood pressure and was expressed in mL.mm Hg.min^--1^.kg^--1^. Exercise tests were performed before and after completion of rehabilitation program on the same machine.

Cardiac rehabilitation {#sec2-6}
----------------------

Patients underwent 2--3 training sessions per week for 7--10 weeks until a total of 20 sessions were completed. Each session was composed of an endurance training part with bicycle exercise and a resistance training part with gymnastics and low weightlifting. The bicycle exercise was executed at an intensity level corresponding to the ventilatory threshold determined at the initial exercise test (assessed by heart rate). Patients who accomplished their assigned intensity level were allowed to gradually increase their work rate and duration. The cycling duration was started from 20 min and progressively increased to 45 min, whereas gymnastics took 30 min. Blood pressure and heart rate were monitored by measurements at rest, during cycling and recovery.

Statistical analysis {#sec2-7}
--------------------

Baseline characteristics were summarized using standard descriptive statistics. Baseline comparisons were made using independent *t* test, Fisher exact tests for dichotomous data, or chi-square tests for categorical data. Paired sample *t* test was used to compare baseline and final cardiopulmonary exercise test variables. Continuous variables were analyzed by Shapiro-Wilk test for normality assumption in both groups and normally distributed continuous data were analyzed by independent samples *t* test. Pearson correlation test was used to explore the relationship between SEVR and the change in peak VO~2~, predicted percent of peak VO~2~, πO~2~, and circulatory power. Partial correlation test was used to correct these relationships for potential confounders (age, systolic and dias- tolic blood pressure, ejection fraction, C~Cr~, and BNP). All analyses were computed using Statistical Package for Social Sciences software (SPSS Version 22; IBM Corporation, Armonk, New York, USA).

Results {#sec1-3}
=======

A total of 76 patients were screened during study period, five patients were excluded because the presence of atrial fibrillation. Of seventy-one consecutive outpatient subjects enrolled, twenty-one patients did not adhere rehabilitation program and quitted at some point before completing 20 exercise sessions. Thus, final study population comprised of fifty patients. There were no electrocardiographically positive ischemic tests or procedure related adverse events during study.

Tonometric measurements {#sec2-8}
-----------------------

Mean baseline SEVR was 1.45±0.29 (range, 0.82--2.19; interquartile range 0.38). The patients were divided into two subgroups with respect to basal median SEVR value (1.445) (Group I, below the median and Group II above the median value). Baseline characteristics of the patients were summarized in [Table 1](#T1){ref-type="table"}. No significant differences have been observed in these demographic and clinical characteristics, except body weight. There were no differences between subgroups with respect to baseline AP (11.2±7.5 vs. 8.8±4.7 mm Hg, respectively; p=0.192), AIx (29±11 vs. 24±11, respectively; p=0.110), and AIx\@75 (22±11 vs. 21±11 mm Hg, respectively; p=0.650).

###### 

Baseline characteristics[\*](#t1f1){ref-type="table-fn"}

                                                                    GROUP I (n=25)      GROUP II (n=25)     *P*
  ----------------------------------------------------------------- ------------------- ------------------- -----------------------------------------
  **Demographic characteristics**                                                                           
   Age, years                                                       54 (47, 65)         57 (47, 68)         0.405
   Male                                                             23 (92)             22 (88)             1.000^[‡](#t1f3){ref-type="table-fn"}^
   White                                                            25 (100)            24 (96)             1.000^[‡](#t1f3){ref-type="table-fn"}^
   Height, m                                                        1.73 (1.69, 1.79)   1.73 (1.67, 1.76)   0.135
   Weight, kg                                                       84 (79, 91)         74 (65, 85)         0.008[\*\*](#t1f2){ref-type="table-fn"}
  **Medical history**                                                                                       
   Hypertension                                                     10 (40)             5 (20)              0.217
   Dyslipidemia                                                     25 (100)            25 (100)            1.000^[‡](#t1f3){ref-type="table-fn"}^
   Diabetes                                                         6 (24)              5 (20)              1.000
   Tobacco use                                                      16 (64)             14 (56)             0.773
   Prior MI                                                         23 (92)             19 (76)             0.247^[‡](#t1f3){ref-type="table-fn"}^
   Prior CABG                                                       2 (8)               4 (16)              0.667^[‡](#t1f3){ref-type="table-fn"}^
  **NYHA functional class**                                                                                 
   I                                                                12 (48)             14 (56)             0.865^[§](#t1f4){ref-type="table-fn"}^
   II                                                               9 (36)              5 (20)              
   III                                                              4 (16)              6 (24)              
  **Clinical measurements**                                                                                 
   Systolic blood pressure,                                         117 (106, 125)      117 (106, 121)      0.975
   mm Hg                                                                                                    
   Diastolic blood pressure,                                        71 (62, 80)         72 (68, 78)         0.660
   mm Hg                                                                                                    
   LVEF, %                                                          49 (38, 62)         53 (43, 64)         0.323
   Hemoglobin, g.dL^--1^                                            14 (12, 15)         14 (13, 14)         0.954
   CCr, mL.min^--1^                                                 93 (70, 122)        91 (74, 110)        0.756
   BNP, pg.mL^--1^                                                  114 (50, 275)       73 (37, 208)        0.245
  **Number of diseased vessels^[†](#t1f5){ref-type="table-fn"}^**                                           
   1                                                                12 (48)             11 (44)             0.738^[§](#t1f4){ref-type="table-fn"}^
   2                                                                7 (28)              7 (28)              
   3                                                                6 (24)              7 (28)              
  **Treatment**                                                                                             
   ACE-I/ARB                                                        22 (88)             21(84)              1.000^[‡](#t1f3){ref-type="table-fn"}^
   Beta-blockers                                                    22 (88)             24 (96)             0.609^[‡](#t1f3){ref-type="table-fn"}^
   Diuretics                                                        2 (8)               8 (32)              0.074^[‡](#t1f3){ref-type="table-fn"}^
   Aldosterone blocker                                              6 (24)              6 (24)              1.000^[‡](#t1f3){ref-type="table-fn"}^
   Statins                                                          25 (100)            25 (100)            1.000^[‡](#t1f3){ref-type="table-fn"}^
   Nitrates                                                         1 (4)               1 (4)               1.000^[‡](#t1f3){ref-type="table-fn"}^

Values are median (25^th^, 75^th^ percentiles) or n (%).

Independent *t* test was used for comparison unless stated.

*P*\<0.01;

Fischer's exact test;

Chi-square test;

The number of coronary arteries with \>50% luminal stenosis on coronary angiography.

ACE-I- angiotensin-converting enzyme inhibitors; ARB- angiotensin receptor blocker; BNP - B-type natriuretic peptide; CABG -coronary artery by-pass grafting; CCr - creatinine clearance (Cockcroft-Gault formula); LVEF- left ventricular ejection fraction; MI- myocardial infarction; NYHA- New York Heart Association

Echocardiographic measurements {#sec2-9}
------------------------------

Echocardiographic measurements were summarized in [Table 2](#T2){ref-type="table"}. The patients in the Group II showed significant improvements in stroke volume index (from 31±5 to 35±5 mL; p=0.008) whereas the patients in Group I showed no improvement in any of echocardiographic parameters. Between these subgroups there were no significant differences with respect to the changes in LVEF or stroke volume index.

###### 

Echocardiographic parameters before and after cardiac rehabilitation

                      Group I (n=25)   Group II (n=25)   *P* for Δ comparison^[‡](#t2f4){ref-type="table-fn"}^                                                                            
  ------------------- ---------------- ----------------- ------------------------------------------------------- ------- ------- ------- ------ ----------------------------------------- -------
  LVEF, %             49±12            50±13             1±6                                                     0.665   53±14   55±15   2±5    0.123                                     0.550
  LVEDVI, mL.m^--2^   61±20            65±21             3±13                                                    0.253   65±26   68±23   3±12   0.198                                     0.981
  LVESVI, mL.m^--2^   32±18            33±17             1±7                                                     0.562   33±26   32±22   0±8    0.906                                     0.629
  SVI, mL             29±8             31±9              2±7                                                     0.154   31±5    35±6    3±6    0.008[\*\*](#t2f2){ref-type="table-fn"}   0.557

∆ indicates the difference between post-cardiac rehabilitation minus pre-cardiac rehabilitation values in each group;

*P*\<0.01;

\*\*\**P*\<0.001;

Paired sample *t* test;

Independent *t* test

LVEDVI - left ventricular end-diastolic volume index; LVEF - left ventricular ejection fraction; LVESVI - left ventricular end-systolic volume index; SVI - stroke volume index

Cardiopulmonary exercise test-based measurements {#sec2-10}
------------------------------------------------

These parameters were summarized in [Table 3](#T3){ref-type="table"}. The patients in the Group II showed significant improvements in peak VO~2~ (from 19.4±5.2 to 22.9±6.7 mL.kg^--1^.min^--1^; p\<0.001), percent of predicted peak VO~2~ (from 72%±18% to 87%±25%; p=0.001), πO~2~ (from 16.1±3.4 to 19.1±4.8 mL O~2~.kg^--1^.beat^--1^; p\<0.001), and circulatory power (from 3262±1353 to 3923±1474 mL.mm Hg.min^--1^.kg^--1^; p=0.004). The patients in the Group I also showed increases in peak VO~2~ (from 21.3±7.0 to 23.5±7.6 mL.kg^--1^.min^--1^; p\<0.001), percent of predicted peak VO~2~ (from 78%±21% to 87%±27%; p=0.002), and circulatory power (from 3601±1455 to 4156±1560 mL.mm Hg.min^--1^.kg^--1^; p=0.001), but not in πO~2~ (from 17.5±4.7 to 18.1±4.2 mL O~2~.kg^--1^.beat^--1^; p=0.252). Between these subgroups there were no significant diffe- rences with respect to the changes in percent of predicted peak VO~2~ and circulatory power. Nevertheless, the change in πO~2~ was significantly higher in the Group II (2.9±3.3 vs. 0.5±2.4; p=0.007) ([Table 3](#T3){ref-type="table"}).

###### 

Cardiopulmonary exercise test parameters before and after cardiac rehabilitation

                                                  Group I (n=25)   Group II (n=25)   *P* for Δ comparison^[‡](#t3f5){ref-type="table-fn"}^                                                                                                                               
  ----------------------------------------------- ---------------- ----------------- ------------------------------------------------------- ------------------------------------------- ----------- ----------- --------- --------------------------------------------- -----------------------------------------
  Peak VO~2~, mL.kg^--1^.min^--1^                 21.3±7.0         23.5±7.6          2.2                                                     0.001[\*\*\*](#t3f3){ref-type="table-fn"}   19.4±5.2    22.9±6.7    3.5       \<0.001[\*\*\*](#t3f3){ref-type="table-fn"}   0.144
  \% of predicted peak VO~2~, %                   78%±21%          87%±27%           9%                                                      0.002[\*\*](#t3f2){ref-type="table-fn"}     72%±18%     87%±25%     15%       0.001[\*\*\*](#t3f3){ref-type="table-fn"}     0.242
  Oxygen pulse (πO~2~), mL O~2~.kg^-1^.beat^-1^   17.5±4.7         18.1±4.2          0.5±2.4                                                 0.252                                       16.1±3.4    19.1±4.8    2.9±3.3   \<0.001[\*\*\*](#t3f3){ref-type="table-fn"}   0.007[\*\*](#t3f2){ref-type="table-fn"}
  Circulatory power, mL.min.mm Hg.kg^--1^         3601±1455        4156±1560         555                                                     0.001[\*\*\*](#t3f3){ref-type="table-fn"}   3262±1353   3923±1474   661       0.004[\*\*](#t3f2){ref-type="table-fn"}       0.680

∆ indicates the difference between post-cardiac rehabilitation minus pre-cardiac rehabilitation values in each group.

*P*\<0.01;

*P*≤0.001;

Paired sample *t* test;

Independent *t* test; Peak VO~2~- Maximal oxygen consumption

When patients were analyzed as a whole group, significant correlations were found between baseline SEVR and the change in peak VO~2~ (r=0.370, p=0.008), predicted percent of peak VO~2~ (r=0.340, p=0.016), πO~2~ (r=0.396, p=0.004) ([Fig. 2](#F2){ref-type="fig"}), but not with circulatory power (r=0.225, p=0.115) and the changes in any of echocardiographic parameters, including the change in LVEF (r=--0.017, p=0.909) and SVI (r=0.069, p=0.635). When these correlations were corrected for potential confoun- ders peak VO~2~ (r=0.272, p=0.070), circulatory power (r=0.140, p=0.358) and predicted percent of peak VO~2~ (r=0.264, p=0.080) lost their significances, bt πO~2~ (r=0.392, p=0.008) remained significant.

![Relation between baseline SEVR and the change in πO~2~ after cardiac rehabilitation. SEVR - subendocardial viability ratio, πO~2~=peak oxygen pulse](AJC-17-37-g002){#F2}

Discussion {#sec1-4}
==========

Our study, for the first time, shows that baseline LV supply--demand relationship may affect the response to CR in terms of improvement in systolic function. Our results indicate that the patients with an unfavorable initial SEVR value may not show improvements in resting and exercise-induced contractile function, as assessed by resting stroke volume index and peak πO~2~, respectively. Of these, peak πO~2~ predominantly reflects peak LV stroke volume during exercise; thus, it is more sensitive to changes in myocardial systolic function compared with those in peak VO~2~, which may be improved by the effects of exercise training on many extracardiac parameters (such as vascular, pulmonary, muscular, autonomic, and inflammatory factors) ([@ref3], [@ref27], [@ref28]). It is also supporting that only the group with a better SEVR showed an increase in stroke volume index, which can be regarded as the resting counterpart of πO~2~.

SEVR, formerly known as Buckberg ratio ([@ref16]), consists of diastolic to systolic pressure-time integral ratio, derived from the pressures measured in the aorta and LV. Systolic pressure time integral is reported to be a reliable index of myocardial oxygen consumption for LV afterload ([@ref12], [@ref13]). Diastolic pressure time integral, on the other hand, takes into account the following three critical factors affecting coronary flow: ([@ref1]) coronary artery diastolic pressure ([@ref14]), which is equal to aortic diastolic pressure in patients with unobstructed coronary arteries; ([@ref2]) the gradient in diastole between coronary arteries pressure and LV pressure; and ([@ref3]) the duration of diastole ([@ref15], [@ref29]). Therefore, SEVR estimates the balance between cardiac blood flow supply and demand.

Although the main aim of CR is increase exercise capacity as a whole, reflected by the improvement in by peak VO~2~, and both groups showed an improvement in peak VO~2~ in our study, patients with a better baseline SEVR showed a better improvement, though statistically insignificant. Our study was not po- wered enough to elucidate whether a better systolic response to CR translates into a greater peak VO~2~ improvement; it serves as a hypothesis generator, calling for larger studies.

Our study also reminds that coronary patency is only one of the several dimensions of optimal myocardial supply--demand relationship, which may be imbalanced enough to hamper positive response to CR despite the absence of a critical stenosis ([@ref17], [@ref30]--[@ref34]). It has been shown that a lower SEVR ratio may limit coronary dilatation capacity even in patients with patent coronary arteries ([@ref20]). SEVR can be negatively influenced by cent- ral and peripheral vasculature via increased wave reflections and large systolic-diastolic pressure undulations caused by increased macrovascular stiffness, decreased compliance, increased peripheral resistance ([@ref16], [@ref18], [@ref34], [@ref35]). Although, we did not find any difference in wave reflection parameters between SEVR subgroups, this may be explained by the limited statistical power of the study. Since cellular regeneration processes are highly intertwined with myocardial energetics ([@ref36]), the failure to improve myocardial systolic function with CR due to a worse supply--demand ratio is highly conceivable.

Lastly, although our study is predominantly a mechanistic one, its results may have a practical message by proposing that some measures may be needed to be undertaken before CR to optimize baseline supply--demand ratio. These may include reducing afterload by decreasing peripheral vascular resistance and wave reflections (e.g., peripheral vasodilators) or augmenting diastolic blood flow by increasing duration of the diastole (e.g., ivabradine). Theoretically, the overall gain from CR may be increased with these priming measures. Further studies are needed for the clarification of these propositions.

Study limitations {#sec2-11}
-----------------

The main limitation of our study is its limited size. Larger studies are needed for clarifying whether a suboptimal myocardial supply--demand lowers maximum benefit from CR in terms of peak VO~2~ improvement. Confounding effects of medications may not be eliminated because they were not withdrawn in the study, even if these medications are usually used in coronary heart disease patients. A second tonometric test after completion of the program may have shown the change in arterial mechanics parameters, which may be of some practical value. We failed measure pulse wave velocity, which may have contributed the article by adding more specific vascular stiffness data on top of vascular reflection parameters. Lastly, SEVR may not directly represent supply--demand relationship of LV. Although systolic part includes aortic systolic pressure and ejection duration as determinants of myocardial oxygen demand, it does not contain other ventricular parameters (such as stroke volume, ventricular mass and shape), which can also influence myocardial energy requirements. Also, diastolic pressure-time index does not take epicardial and microvascular resistance into account, which may overestimate coronary flow, especially in patients with significant coronary stenoses.

Conclusion {#sec1-5}
==========

Our study shows that baseline supply--demand imbalance, as measured by SEVR, may limit systolic improvement response to CR in patients with CAD. Further studies are needed to elucidate whether this limitation lowers maximum achievable peak VO~2~ improvement with CR. Furthermore, the measures optimizing baseline supply--demand ratio and their effects on CR results need to be clarified.
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